BHA536 is an orally active selective inhibitor for PKCalpha/beta and NF-kB signaling pathway. BHA536 inhibits the proliferation of CD79-mutated ABC DLBCL cell, arrests cell cycle at G1 phase, and induces apoptosis in TMD8 cell. BHA536 exhibits antitumor efficacy in mice[1].
Molecular Weight:
548.03
CAS Number:
[919992-85-1]
Formula:
C30H30ClN3O5
Target:
Apoptosis,NF-kappaB,PKC
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
